Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Sentinel Node Tumor Burden According to the Rotterdam Criteria Is the Most Important Prognostic Factor for Survival in Melanoma Patients
253
Zitationen
9
Autoren
2008
Jahr
Abstract
This large multicenter dataset establishes that patients with SUB-micrometastases <0.1 mm have the same prognosis as SN negative patients and can be spared a CLND. A <0.2 mm cut-off for SUB-micrometastases does not seem correct for melanoma, as 10% additional nodal positivity is found.
Ähnliche Arbeiten
Dermatologist-level classification of skin cancer with deep neural networks
2017 · 13.418 Zit.
Tumor Angiogenesis: Therapeutic Implications
1971 · 10.106 Zit.
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
2011 · 7.664 Zit.
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 · 4.558 Zit.
Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma
1992 · 4.401 Zit.